But some biologics API is literally millions per kg
November 2, 2026 at 8:26 PM
But some biologics API is literally millions per kg
honestly it's a big pain in the ass. I can't even take testosterone until I get back on biologics
November 2, 2026 at 11:12 PM
honestly it's a big pain in the ass. I can't even take testosterone until I get back on biologics
Der Gesundheitskonzern setzt beim Ausbau seines wachsenden Geschäfts mit Nachahmer-Medikamenten auf den chinesischen Partner WuXi Biologics.
Biopharma: Fresenius baut Geschäft mit Nachahmer-Medikamenten aus
Der Gesundheitskonzern setzt beim Ausbau seines wachsenden Geschäfts mit Nachahmer-Medikamenten auf den chinesischen Partner WuXi Biologics.
www.wiwo.de
November 2, 2026 at 11:50 AM
Der Gesundheitskonzern setzt beim Ausbau seines wachsenden Geschäfts mit Nachahmer-Medikamenten auf den chinesischen Partner WuXi Biologics.
Fresenius took options on up to 37 biosimilars from WuXi Biologics over the next decade in one of the largest such deals to date.
Fresenius taps WuXi Biologics for up to 37 biosimilars over next decade
Fresenius gets exclusive options on up to 37 WuXi Biologics biosimilar candidates, potentially more than doubling its 29-molecule portfolio.
endpoints.news
November 3, 2026 at 4:42 PM
Fresenius took options on up to 37 biosimilars from WuXi Biologics over the next decade in one of the largest such deals to date.
Fresenius will bei Biosimilars in die Sandoz-Liga aufsteigen
Fresenius sichert sich 37 Biosimilar-Optionen von WuXi Biologics. Mit dieser Entwicklungsvereinbarung baut Fresenius seine Biopharma-Ambitionen deutlich aus.
transkript.de/artikel/2026...
Fresenius sichert sich 37 Biosimilar-Optionen von WuXi Biologics. Mit dieser Entwicklungsvereinbarung baut Fresenius seine Biopharma-Ambitionen deutlich aus.
transkript.de/artikel/2026...
Großdeal: Fresenius will bei Biosimilars in die Sandoz-Liga aufsteigen
Fresenius sichert sich 37 Biosimilar-Optionen von WuXi Biologics. Mit dieser Entwicklungsvereinbarung baut Fresenius seine Biopharma-Ambitionen deutlich aus. Der Deal fällt in eine Phase, in der zahlr...
transkript.de
November 3, 2026 at 10:28 AM
Fresenius will bei Biosimilars in die Sandoz-Liga aufsteigen
Fresenius sichert sich 37 Biosimilar-Optionen von WuXi Biologics. Mit dieser Entwicklungsvereinbarung baut Fresenius seine Biopharma-Ambitionen deutlich aus.
transkript.de/artikel/2026...
Fresenius sichert sich 37 Biosimilar-Optionen von WuXi Biologics. Mit dieser Entwicklungsvereinbarung baut Fresenius seine Biopharma-Ambitionen deutlich aus.
transkript.de/artikel/2026...
Can gene editing stop ALS? Toronto’s Specific Biologics advances therapy that could help some with fatal disease, raises US$35 million from investors
www.theglobeandmail.com/business/art...
www.theglobeandmail.com/business/art...
Can gene editing stop ALS? Toronto’s Specific Biologics advances therapy that could help some with fatal disease
Western University spinout raises $35-million after generating promising pre-clinical results
www.theglobeandmail.com
November 2, 2026 at 1:19 PM
Can gene editing stop ALS? Toronto’s Specific Biologics advances therapy that could help some with fatal disease, raises US$35 million from investors
www.theglobeandmail.com/business/art...
www.theglobeandmail.com/business/art...
Casualitat feliç que el capítol 1312 de l'En guàrdia! tracti de la policia i el sistema judicial jugant amb la frenologia 🥲
share.google/GOC7zMgmsfBU...
share.google/GOC7zMgmsfBU...
En guàrdia! - Cesare Lombroso i l'antropologia criminal - 3Cat
Capítol 1312. Al llarg de la història, en l'estudi de la delinqüència han confluït factors socials, culturals, ambientals... i fins i tot biològics. L'antropologia criminal, sorgida al segle XIX, sost...
share.google
November 1, 2026 at 4:59 PM
Casualitat feliç que el capítol 1312 de l'En guàrdia! tracti de la policia i el sistema judicial jugant amb la frenologia 🥲
share.google/GOC7zMgmsfBU...
share.google/GOC7zMgmsfBU...
The idea that biologics that have not undergone a regulatory GMP approval are going to become available for purchase (without even a prescription!) is insane.
This is 100% going to end up with people being poisoned by organic solvent carryover in the final drug product.
This is 100% going to end up with people being poisoned by organic solvent carryover in the final drug product.
November 2, 2026 at 2:46 PM
The idea that biologics that have not undergone a regulatory GMP approval are going to become available for purchase (without even a prescription!) is insane.
This is 100% going to end up with people being poisoned by organic solvent carryover in the final drug product.
This is 100% going to end up with people being poisoned by organic solvent carryover in the final drug product.
My doctor went over biologics with me at our telehealth today and as he listed them I could hear all their dumb commercials in my head. Just glad we didn't settle on Skyrizi which is the stupidest name of all.
November 2, 2026 at 10:33 PM
My doctor went over biologics with me at our telehealth today and as he listed them I could hear all their dumb commercials in my head. Just glad we didn't settle on Skyrizi which is the stupidest name of all.
Hear updates from Academia and Industry on the State of Spinal Biologics.
Secure your seat at www.spine.org/Biologics
Secure your seat at www.spine.org/Biologics
November 1, 2026 at 2:50 PM
Hear updates from Academia and Industry on the State of Spinal Biologics.
Secure your seat at www.spine.org/Biologics
Secure your seat at www.spine.org/Biologics
Fresenius signs biosimilars pipeline agreement with WuXi Biologics reut.rs/4ien4JO
Fresenius signs biosimilars pipeline agreement with WuXi Biologics
Fresenius has signed a development agreement for biosimilar drugs with China's WuXi Biologics , the German healthcare group said on Monday.
reut.rs
November 2, 2026 at 6:35 AM
Fresenius signs biosimilars pipeline agreement with WuXi Biologics reut.rs/4ien4JO
Samsung Biologics Achieves Unprecedented 'Negligible Risk' in ESG Ratings Evaluation#Sustainability#South_Korea#ESG_Rating#Samsung_Biologics#Incheon
Samsung Biologics Achieves Unprecedented 'Negligible Risk' in ESG Ratings Evaluation
Samsung Biologics has reached a 'Negligible Risk' level in its ESG assessment by Morningstar Sustainalytics, reflecting its commitment to sustainable practices.
third-news.com
November 3, 2026 at 11:43 PM
Samsung Biologics Achieves Unprecedented 'Negligible Risk' in ESG Ratings Evaluation#Sustainability#South_Korea#ESG_Rating#Samsung_Biologics#Incheon
YOLOing biologics onto the market is such a bad idea im so mad
October 28, 2026 at 6:23 PM
YOLOing biologics onto the market is such a bad idea im so mad
Fresenius and WuXi Biologics Strike Groundbreaking Deal to Advance Biosimilars Development Pipeline#Germany#WuXi_Biologics#Biosimilars#Bad_Homburg#Fresenius
Fresenius and WuXi Biologics Strike Groundbreaking Deal to Advance Biosimilars Development Pipeline
Fresenius and WuXi Biologics have signed an exclusive agreement to develop up to 37 biosimilars, significantly expanding Fresenius' pipeline and market reach.
third-news.com
November 2, 2026 at 7:09 AM
Fresenius and WuXi Biologics Strike Groundbreaking Deal to Advance Biosimilars Development Pipeline#Germany#WuXi_Biologics#Biosimilars#Bad_Homburg#Fresenius
#RecercaUIB | ⚛️ Investigadors de la #UIB participen en un estudi que descriu per primera vegada la presència d’un tipus d’interacció molecular anomenada «enllaç de titani» ('titan bond') en sistemes biològics.
@pubs.acs.org @acs.org
🔗 Llegeix la notícia! diari.uib.cat/w/la-uib-ide...
@pubs.acs.org @acs.org
🔗 Llegeix la notícia! diari.uib.cat/w/la-uib-ide...
November 2, 2026 at 11:47 AM
#RecercaUIB | ⚛️ Investigadors de la #UIB participen en un estudi que descriu per primera vegada la presència d’un tipus d’interacció molecular anomenada «enllaç de titani» ('titan bond') en sistemes biològics.
@pubs.acs.org @acs.org
🔗 Llegeix la notícia! diari.uib.cat/w/la-uib-ide...
@pubs.acs.org @acs.org
🔗 Llegeix la notícia! diari.uib.cat/w/la-uib-ide...
Fresenius has signed a development agreement for biosimilar drugs with China's WuXi Biologics , the German healthcare group said on Monday.
Fresenius signs biosimilars pipeline agreement with WuXi Biologics
Fresenius has signed a development agreement for biosimilar drugs with China's WuXi Biologics , the German healthcare group said on Monday.
reut.rs
November 2, 2026 at 7:05 AM
Fresenius has signed a development agreement for biosimilar drugs with China's WuXi Biologics , the German healthcare group said on Monday.
Last chance!
Promega Biologics Symposium 2026 is this Thursday 5 November at Bee House, Milton Park, Oxfordshire. Only a few spaces remain.
You will need to register today at: https://ow.ly/LlyL50ZZNCr
#Biologics #DrugDiscovery
Promega Biologics Symposium 2026 is this Thursday 5 November at Bee House, Milton Park, Oxfordshire. Only a few spaces remain.
You will need to register today at: https://ow.ly/LlyL50ZZNCr
#Biologics #DrugDiscovery
November 3, 2026 at 9:05 AM
Last chance!
Promega Biologics Symposium 2026 is this Thursday 5 November at Bee House, Milton Park, Oxfordshire. Only a few spaces remain.
You will need to register today at: https://ow.ly/LlyL50ZZNCr
#Biologics #DrugDiscovery
Promega Biologics Symposium 2026 is this Thursday 5 November at Bee House, Milton Park, Oxfordshire. Only a few spaces remain.
You will need to register today at: https://ow.ly/LlyL50ZZNCr
#Biologics #DrugDiscovery
Dr. Tina Bartosik represented the Vienna Airway Lab at ORL Danube Symposium 2026 in Belgrade, presenting the new EUFORIA Pocket Guide on biologics in airway diseases.
Great exchange on rhinology and the unified airway!
#Rhinology #CRSwNP #Biologics #MedUniVie
Great exchange on rhinology and the unified airway!
#Rhinology #CRSwNP #Biologics #MedUniVie
October 30, 2026 at 7:29 AM
Dr. Tina Bartosik represented the Vienna Airway Lab at ORL Danube Symposium 2026 in Belgrade, presenting the new EUFORIA Pocket Guide on biologics in airway diseases.
Great exchange on rhinology and the unified airway!
#Rhinology #CRSwNP #Biologics #MedUniVie
Great exchange on rhinology and the unified airway!
#Rhinology #CRSwNP #Biologics #MedUniVie
Specific Biologics Secures $35 Million in Funding to Advance ALS Gene-Editing Therapy#Canada#Toronto#ALS#Specific_Biologics#Dualase
Specific Biologics Secures $35 Million in Funding to Advance ALS Gene-Editing Therapy
Specific Biologics announces a successful $35 million Series A funding round aimed at developing a revolutionary gene-editing therapy for ALS, enhancing hope for patients.
third-news.com
November 2, 2026 at 3:44 PM
Specific Biologics Secures $35 Million in Funding to Advance ALS Gene-Editing Therapy#Canada#Toronto#ALS#Specific_Biologics#Dualase
Specific Biologics Secures $35 Million Series A Financing to Propel Gene-Editing Therapy for ALS#Canada#Toronto#ALS_Treatment#Specific_Biologics#Dualase
Specific Biologics Secures $35 Million Series A Financing to Propel Gene-Editing Therapy for ALS
Specific Biologics has successfully closed a $35 million Series A funding round to advance its Dualase® gene-editing therapy targeting ALS, promising a revolutionary treatment for patients.
third-news.com
November 2, 2026 at 3:42 PM
Specific Biologics Secures $35 Million Series A Financing to Propel Gene-Editing Therapy for ALS#Canada#Toronto#ALS_Treatment#Specific_Biologics#Dualase
Nice framing. US regulators drew the same line a bit lower: since March 2020 the FDA treats chains over 40 amino acids as proteins, regulated as biologics. That's why insulin, at 51, moved over to the biologics pathway that year.
November 3, 2026 at 2:21 AM
Nice framing. US regulators drew the same line a bit lower: since March 2020 the FDA treats chains over 40 amino acids as proteins, regulated as biologics. That's why insulin, at 51, moved over to the biologics pathway that year.